Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Badenes Bonet, Diana, 1987-
• dc.contributor.author Cejudo, Pilar
• dc.contributor.author Rodó-Pin, Anna
• dc.contributor.author Martín-Ontiyuelo, Clara
• dc.contributor.author Chalela Rengifo, Roberto José, 1985-
• dc.contributor.author Rodríguez-Portal, Jose Antonio
• dc.contributor.author Vázquez-Sánchez, Rosa
• dc.contributor.author Gea Guiral, Joaquim
• dc.contributor.author Duran Jordà, Xavier, 1974-
• dc.contributor.author Caguana Vélez, Oswaldo Antonio
• dc.contributor.author Rodriguez-Chiaradia, Diego Agustín
• dc.contributor.author Balcells Vilarnau, Eva, 1967-
• dc.date.accessioned 2021-12-09T07:01:39Z
• dc.date.available 2021-12-09T07:01:39Z
• dc.date.issued 2021
• dc.description.abstract Background: Supplemental oxygen delivered with standard oxygen therapy (SOT) improves exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). Although high-flow nasal cannula oxygen therapy (HFNC) improves oxygenation in other respiratory diseases, its impact on exercise performance has never been evaluated in IPF patients. We hypothesized that HFNC may improve exercise capacity in IPF subjects compared to SOT. Methods: This was a prospective, crossover, pilot randomized trial that compared both oxygenation methods during a constant submaximal cardiopulmonary exercise test (CPET) in IPF patients with exertional oxygen saturation (SpO2) ≤ 85% in the 6-min walking test. The primary outcome was endurance time (Tlim). Secondary outcomes were muscle oxygen saturation (StO2) and respiratory and leg symptoms. Results: Ten IPF patients [71.7 (6) years old, 90% males] were included. FVC and DLCO were 58 ± 11% and 31 ± 13% pred. respectively. Tlim during CPET was significantly greater using HFNC compared to SOT [494 ± 173 vs. 381 ± 137 s, p = 0.01]. HFNC also associated with a higher increase in inspiratory capacity (IC) [19.4 ± 14.2 vs. 7.1 ± 8.9%, respectively; p = 0.04], and a similar trend was observed in StO2 during exercise. No differences were found in respiratory or leg symptoms between the two oxygen devices. Conclusions: This is the first study demonstrating that HFNC oxygen therapy improves exercise tolerance better than SOT in IPF patients with exertional desaturation. This might be explained by changes in ventilatory mechanics and muscle oxygenation. Further and larger studies are needed to confirm the benefits of HFNC in IPF patients and its potential usefulness in rehabilitation programs.
• dc.format.mimetype application/pdf
• dc.identifier.citation Badenes-Bonet D, Cejudo P, Rodó-Pin A, Martín-Ontiyuelo C, Chalela R, Rodríguez-Portal JA, Vázquez-Sánchez R, Gea J, Duran X, Caguana OA, Rodriguez-Chiaradia DA, Balcells E. Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial. BMC Pulm Med. 2021;21(1):355. DOI: 10.1186/s12890-021-01727-9
• dc.identifier.doi http://dx.doi.org/10.1186/s12890-021-01727-9
• dc.identifier.issn 1471-2466
• dc.identifier.uri http://hdl.handle.net/10230/49154
• dc.language.iso eng
• dc.publisher BioMed Central
• dc.relation.ispartof BMC Pulm Med. 2021;21(1):355
• dc.rights © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword Exertional desaturation
• dc.subject.keyword High-flow nasal cannula
• dc.subject.keyword Idiopathic pulmonary fibrosis
• dc.subject.keyword Oxygen therapy
• dc.title Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion